GGrantIndex
← Leaderboards

Steven K Clinton

Ohio State University

$5,749,067
Attributed
$10,392,333
Total exposure
13
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.8M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$10,392,333 · 13

By mechanism

U01$4,224,581 · 2
R01$4,051,756 · 4
P30$1,047,092 · 5
R21$658,731 · 1
T32$410,173 · 1

Most similar at Ohio State University

Same institution · by research overlap

Others in their field

Top investigators on “Malignant Neoplasms

Research focus

Malignant NeoplasmsPhytochemicalFoodClinical ResearchFutureIn VitroMolecularClinical TrialsDietMetabolismBiologicalProgramsBasePreventionPublicationsAreaFundingTechnologyMetabolomicsGenomicsResearch PersonnelExposure ToCancer RiskPublishing

Grant awards (50)

Shared Resource 12: Nutrient and Phytochemical Analytics (NPASR)$103,715
P30 · FY2025 · CA · contact PI
Project 04: Molecular Carcinogenesis and Chemoprevention (MCC)$51,273
P30 · FY2025 · CA · contact PI
Shared Resource 12: Nutrient and Phytochemical Analytics (NPASR)$105,498
P30 · FY2024 · CA · contact PI
Project 04: Molecular Carcinogenesis and Chemoprevention (MCC)$52,154
P30 · FY2024 · CA · contact PI
Shared Resource 12: Nutrient and Phytochemical Analytics (NPASR)$105,500
P30 · FY2023 · CA · contact PI
Project 04: Molecular Carcinogenesis and Chemoprevention (MCC)$52,152
P30 · FY2023 · CA · contact PI
Shared Resource 12: Nutrient and Phytochemical Analytics (NPASR)$105,500
P30 · FY2022 · CA · contact PI
Project 04: Molecular Carcinogenesis and Chemoprevention (MCC)$52,152
P30 · FY2022 · CA · contact PI
Role of oncogenic phosphorylated MED1 in aggressive prostate cancer$413,691
R01 · FY2021 · CA
Shared Resource 12: Nutrient and Phytochemical Analytics (NPASR)$105,500
P30 · FY2021 · CA · contact PI
Project 04: Molecular Carcinogenesis and Chemoprevention (MCC)$52,152
P30 · FY2021 · CA · contact PI
Combined breast MRI/biomarker strategies to identify aggressive biology$649,862
U01 · FY2020 · CA
Role of oncogenic phosphorylated MED1 in aggressive prostate cancer$383,629
R01 · FY2020 · CA
Molecular Carcinogenesis and Chemoprevention Research Program (MCC)$48,693
P30 · FY2020 · CA · contact PI
Role of oncogenic phosphorylated MED1 in aggressive prostate cancer$372,120
R01 · FY2019 · CA
Interactive Omics: Black raspberry metabolites and the oral microbiome in smokers$316,329
U01 · FY2019 · CA · contact PI
Molecular Carcinogenesis and Chemoprevention Research Program (MCC)$53,293
P30 · FY2019 · CA · contact PI
Interactive Omics: Black raspberry metabolites and the oral microbiome in smokers$587,041
U01 · FY2018 · CA
Role of oncogenic phosphorylated MED1 in aggressive prostate cancer$386,836
R01 · FY2018 · CA
Translating Novel Antitumor Targets of Vitamin E into New Chemopreventive Agents$319,550
R01 · FY2018 · CA · contact PI
Modulation of antitumor immunity by dietary soy and its isoflavone constituents$319,549
R01 · FY2018 · CA · contact PI
Validation studies for interactive omics: Black raspberry metabolites and the oral microbiome in smokers$156,000
U01 · FY2018 · CA
Molecular Carcinogenesis and Chemoprevention Research Program (MCC)$65,564
P30 · FY2018 · CA · contact PI
Molecular Carcinogenesis and Chemoprevention Research Program (MCC)$4,572
P30 · FY2018 · CA · contact PI
Molecular Carcinogenesis and Chemoprevention Research Program (MCC)$2,399
P30 · FY2018 · CA · contact PI
Molecular Carcinogenesis and Chemoprevention Research Program (MCC)$2,390
P30 · FY2018 · CA · contact PI
Molecular Carcinogenesis and Chemoprevention Research Program (MCC)$2,022
P30 · FY2018 · CA · contact PI
Role of oncogenic phosphorylated MED1 in aggressive prostate cancer$340,403
R01 · FY2017 · CA
Translating Novel Antitumor Targets of Vitamin E into New Chemopreventive Agents$319,550
R01 · FY2017 · CA · contact PI
Interactive Omics: Black raspberry metabolites and the oral microbiome in smokers$273,086
U01 · FY2017 · CA
Role of oncogenic phosphorylated MED1 in aggressive prostate cancer$52,914
R01 · FY2017 · CA
Molecular Carcinogenesis and Chemoprevention Research Program (MCC)$46,262
P30 · FY2017 · CA · contact PI
Modulation of antitumor immunity by dietary soy and its isoflavone constituents$1
R01 · FY2017 · CA · contact PI
Interactive Omics: Black raspberry metabolites and the oral microbiome in smokers$615,114
U01 · FY2016 · CA
Training Hematology and Oncology Fellows in Clinical Research$203,478
T32 · FY2016 · CA
Interactive Omics: Black raspberry metabolites and the oral microbiome in smokers$156,806
U01 · FY2016 · CA
Molecular Carcinogenesis and Chemoprevention Research Program (MCC)$36,301
P30 · FY2016 · CA · contact PI
Interactive Omics: Black raspberry metabolites and the oral microbiome in smokers$630,892
U01 · FY2015 · CA
Training Hematology and Oncology Fellows in Clinical Research$206,695
T32 · FY2015 · CA
Interactive Omics: Black raspberry metabolites and the oral microbiome in smokers$157,485
U01 · FY2015 · CA
Interactive Omics: Black raspberry metabolites and the oral microbiome in smokers$45,147
U01 · FY2015 · CA
Interactive Omics: Black raspberry metabolites and the oral microbiome in smokers$636,819
U01 · FY2014 · CA
Novel 13-C Tomato Carotenoids for Absorption and Metabolism Studies in Humans$185,013
R21 · FY2012 · AT · contact PI
Novel 13-C Tomato Carotenoids for Absorption and Metabolism Studies in Humans$48,291
R21 · FY2012 · AT · contact PI
Novel 13-C Tomato Carotenoids for Absorption and Metabolism Studies in Humans$224,198
R21 · FY2011 · AT · contact PI
Novel 13-C Tomato Carotenoids for Absorption and Metabolism Studies in Humans$201,229
R21 · FY2010 · AT · contact PI
Tomato-Soy Juice for Prostate Cancer$279,963
R01 · FY2008 · CA · contact PI
Tomato-Soy Juice for Prostate Cancer$279,963
R01 · FY2007 · CA · contact PI
Tomato-Soy Juice for Prostate Cancer$288,324
R01 · FY2006 · CA · contact PI
Tomato-Soy Juice for Prostate Cancer$295,263
R01 · FY2005 · CA